Form 10-Q - Quarterly report [Sections 13 or 15(d)]

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

FibroGen (NASDAQ:FGEN)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas FibroGen.

FibroGen (NASDAQ:FGEN)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas FibroGen.

Noticias sobre FibroGen Inc FGEN

Traders Rush To Buy Biotech Following Q1 Earnings Beat
Martes 7 de Mayo 2024 (2 semanas hace) • AllPennyStocks.com

FibroGen to Participate in Upcoming Investor Conferences
Martes 7 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 6 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 6 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

FibroGen Reports First Quarter 2024 Financial Results
Lunes 6 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

FibroGen to Report First Quarter 2024 Financial Results
Lunes 29 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology A
Miércoles 24 de Abril 2024 (4 semanas hace) • GlobeNewswire Inc.

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
Martes 2 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
Martes 26 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Lunes 11 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 8 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 8 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Más de FibroGen Inc Artículos de Noticias

Primoris Services

Expeditors International...

Beard Energy Transition ...

NLBNPIT1XYZ0 20241220 8....

NLBNPIT1W288 20240920 2000

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones